Positron emission tomography identifies cerebral glucose metabolism to determine regardless of whether brain activity is lessened in unique locations. On the other hand, these treatments have minimal diagnostic sensitivity for a few neurologic disorders and can't assess the functional output in the Mind. Neuropsychological screening presents an aim